In 2017, Zhou et al. reported how pectolinarigenin suppresses pancreatic cancer cells (Patu 8988 and BxPC-3) growth by inhibiting STAT3 signaling. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.